CoChat

Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis

Ley, Benedikt, Winasti Satyagraha, Ari, Rahmat, Hisni, von Fricken, Michael E., Douglas, Nicholas M., Pfeffer, Daniel A., Espino, Fe, von Seidlein, Lorenz, Henriques, Gisela, Oo, Nwe Nwe, Menard, Didier, Parikh, Sunil, Bancone, Germana, Karahalios, Amalia, Price, Ric N. · 2019 · PLOS Medicine
Cited by 48

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1002992

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Flow chart on article selection.
Fig 1 Flow chart on article selection.CC BY · PubMed Central
Fig 2 Forest plot: Sensitivity. Threshold for G6PDd is calculated based on the site-specific AMM. Study ID is identified by first author, country of sample collection, and type of blood used. AMM, adjusted male median; G6PDd, glucose-6-phosphate dehydrogenase deficiency.
Fig 2 Forest plot: Sensitivity. Threshold for G6PDd is calculated based on the site-specific AMM. Study ID is identified by first author, country of sample collection, and type of blood used. AMM, adjusted male median; G6PDd, glucose-6-phosphate dehydrogenase deficiency.CC BY · PubMed Central
Fig 3 Forest plot: Specificity. Threshold for G6PDd is calculated based on the site-specific AMM. Study ID is identified by first author, country of sample collection, and type of blood used. AMM, adjusted male median; G6PDd, glucose-6-phosphate dehydrogenase deficiency.
Fig 3 Forest plot: Specificity. Threshold for G6PDd is calculated based on the site-specific AMM. Study ID is identified by first author, country of sample collection, and type of blood used. AMM, adjusted male median; G6PDd, glucose-6-phosphate dehydrogenase deficiency.CC BY · PubMed Central
Fig 4 Qualitative assessment of included studies (QUADAS2). QUADAS2, Quality Assessment of Diagnostic Accuracy Studies.
Fig 4 Qualitative assessment of included studies (QUADAS2). QUADAS2, Quality Assessment of Diagnostic Accuracy Studies.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 43

  1. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: neglected and not benign. The American journal of tropical medicine and hygiene. 2007; 77(6 Suppl): 79– 87. 18165478 PMC2653940 · DOI · Paper page
  2. Recht J, Ashley EA, White NJ. Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries. PLoS neglected tropical diseases. 2018; 12(4): e0006230 10.1371/journal.pntd.0006230 29672516 PMC5908060 · DOI · Paper page
  3. ARMY giving primaquine treatment to all returning servicemen. Public Health Rep. 1952; 67(2): 178– 9. 14900346
  4. WHO. Guidelines for the treatment of malaria - 3rd Edition Switzerland: WHO; 2015.
  5. John GK, Douglas NM, von Seidlein L, Nosten F, Baird JK, White NJ, et al Primaquine radical cure of Plasmodium vivax: a critical review of the literature. Malaria journal. 2012; 11: 280 10.1186/1475-2875-11-280 22900786 PMC3489597 · DOI · Paper page
  6. Baird JK, Hoffman SL. Primaquine therapy for malaria. Clin Infect Dis. 2004; 39(9): 1336– 45. 10.1086/424663 15494911 · DOI · Paper page
  7. Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits. Malaria journal. 2014; 13: 418 10.1186/1475-2875-13-418 25363455 PMC4230503 · DOI · Paper page
  8. Commons RJ, Simpson JA, Thriemer K, Humphreys GS, Abreha T, Alemu SG, et al The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis. The Lancet Infectious diseases. 2018; 18(9): 1025– 34. 10.1016/S1473-3099(18)30348-7 30033231 PMC6105624 · DOI · Paper page
  9. Gomez-Manzo S, Marcial-Quino J, Vanoye-Carlo A, Serrano-Posada H, Ortega-Cuellar D, Gonzalez-Valdez A, et al Glucose-6-Phosphate Dehydrogenase: Update and Analysis of New Mutations around the World. Int J Mol Sci. 2016; 17(12). PMC5187869 27941691 · DOI · Paper page
  10. Minucci A, Moradkhani K, Hwang MJ, Zuppi C, Giardina B, Capoluongo E. Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the "old" and update of the new mutations. Blood Cells Mol Dis. 2012; 48(3): 154– 65. 10.1016/j.bcmd.2012.01.001 22293322 · doi:10.1016/j.bcmd.2012.01.001
  11. Luzzatto L. Glucose 6-phosphate dehydrogenase deficiency: from genotype to phenotype. Haematologica. 2006; 91(10): 1303– 6. 17018377
  12. Chu CS, Bancone G, Moore KA, Win HH, Thitipanawan N, Po C, et al Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens. PLoS medicine. 2017; 14(2): e1002224 10.1371/journal.pmed.1002224 28170391 PMC5295665 · DOI · Paper page
  13. Chu CS, Bancone G, Nosten F, White NJ, Luzzatto L. Primaquine-induced haemolysis in females heterozygous for G6PD deficiency. Malaria journal. 2018; 17(1): 101 10.1186/s12936-018-2248-y 29499733 PMC5833093 · DOI · Paper page
  14. von Seidlein L, Auburn S, Espino F, Shanks D, Cheng Q, McCarthy J, et al Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malaria journal. 2013; 12: 112 10.1186/1475-2875-12-112 23537118 PMC3616837 · DOI · Paper page
  15. Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, et al G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malaria journal. 2013; 12: 391 10.1186/1475-2875-12-391 24188096 PMC3830439 · DOI · Paper page
  16. Ley B, Luter N, Espino FE, Devine A, Kalnoky M, Lubell Y, et al The challenges of introducing routine G6PD testing into radical cure: a workshop report. Malaria journal. 2015; 14: 377 10.1186/s12936-015-0896-8 26416229 PMC4587750 · DOI
  17. Beutler E. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood. 2008; 111(1): 16– 24. 10.1182/blood-2007-04-077412 18156501 · DOI · Paper page
  18. Kim S, Nguon C, Guillard B, Duong S, Chy S, Sum S, et al Performance of the CareStart G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PloS one. 2011; 6(12): e28357 10.1371/journal.pone.0028357 22164279 PMC3229584 · DOI · Paper page
  19. Henriques G, Phommasone K, Tripura R, Peto TJ, Raut S, Snethlage C, et al Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia. Malaria journal. 2018; 17(1): 243 10.1186/s12936-018-2390-6 29929514 PMC6013858 · DOI
  20. Bancone G, Chu CS, Chowwiwat N, Somsakchaicharoen R, Wilaisrisak P, Charunwatthana P, et al Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests. The American journal of tropical medicine and hygiene. 2015; 92(4): 818– 24. 10.4269/ajtmh.14-0696 25646252 PMC4385780 · DOI · Paper page
  21. Banoo S, Bell D, Bossuyt P, Herring A, Mabey D, Poole F, et al Evaluation of diagnostic tests for infectious diseases: general principles. Nature reviews Microbiology. 2006; 4(12 Suppl): S20– 32. 10.1038/nrmicro1570 17366684 · DOI
  22. Ley B, Bancone G, von Seidlein L, Thriemer K, Richards JS, Domingo GJ, et al Methods for the field evaluation of quantitative G6PD diagnostics: a review. Malaria journal. 2017; 16(1): 361 10.1186/s12936-017-2017-3 28893237 PMC5594530 · DOI · Paper page
  23. Riley RD, Dodd SR, Craig JV, Thompson JR, Williamson PR. Meta-analysis of diagnostic test studies using individual patient data and aggregate data. Statistics in medicine. 2008; 27(29): 6111– 36. 10.1002/sim.3441 18816508 · DOI · Paper page
  24. Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS medicine. 2012; 9(11): e1001339 10.1371/journal.pmed.1001339 23152723 PMC3496665 · DOI · Paper page
  25. McGee S. Simplifying likelihood ratios. J Gen Intern Med. 2002; 17(8): 646– 9. 10.1046/j.1525-1497.2002.10750.x 12213147 PMC1495095 · DOI · Paper page
  26. Simundic AM. Measures of Diagnostic Accuracy: Basic Definitions. EJIFCC. 2009; 19(4): 203– 11. 27683318 PMC4975285
  27. Espino FE, Bibit JA, Sornillo JB, Tan A, von Seidlein L, Ley B. Comparison of Three Screening Test Kits for G6PD Enzyme Deficiency: Implications for Its Use in the Radical Cure of Vivax Malaria in Remote and Resource-Poor Areas in the Philippines. PloS one. 2016; 11(2): e0148172 10.1371/journal.pone.0148172 26849445 PMC4743845 · DOI · Paper page
  28. Oo NN, Bancone G, Maw LZ, Chowwiwat N, Bansil P, Domingo GJ, et al Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar. PloS one. 2016; 11(4): e0152304 10.1371/journal.pone.0152304 27035821 PMC4818080 · DOI · Paper page
  29. Roca-Feltrer A, Khim N, Kim S, Chy S, Canier L, Kerleguer A, et al Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia. PloS one. 2014; 9(12): e116143 10.1371/journal.pone.0116143 25541721 PMC4277465 · DOI · Paper page
  30. Satyagraha AW, Sadhewa A, Elvira R, Elyazar I, Feriandika D, Antonjaya U, et al Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia. PLoS neglected tropical diseases. 2016; 10(2): e0004457 10.1371/journal.pntd.0004457 26894297 PMC4760930 · DOI · Paper page
  31. Roh ME, Oyet C, Orikiriza P, Wade M, Mwanga-Amumpaire J, Boum Y 2nd, et al Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda. The American journal of tropical medicine and hygiene. 2016; 95(5): 1094– 9. 10.4269/ajtmh.16-0552 27672207 PMC5094223 · doi:10.4269/ajtmh.16-0552
  32. von Fricken ME, Weppelmann TA, Eaton WT, Masse R, Beau de Rochars MV, Okech BA. Performance of the CareStart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti. The American journal of tropical medicine and hygiene. 2014; 91(1): 77– 80. 10.4269/ajtmh.14-0100 24778197 PMC4080573 · DOI
  33. Brito MA, Peixoto HM, Almeida AC, Oliveira MR, Romero GA, Moura-Neto JP, et al Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon. Rev Soc Bras Med Trop. 2016; 49(4): 446– 55. 10.1590/0037-8682-0134-2016 27598631 · DOI
  34. Abdul-Ghani R, Mahdy MA, Saif-Ali R, Alkubati SA, Alqubaty AR, Al-Mikhlafy AA, et al Glucose-6-phosphate dehydrogenase deficiency among Yemeni children residing in malaria-endemic areas of Hodeidah governorate and evaluation of a rapid diagnostic test for its detection. Malaria journal. 2016; 15: 327 10.1186/s12936-016-1372-9 27329471 PMC4915072 · DOI
  35. Adu-Gyasi D, Asante KP, Newton S, Dosoo D, Amoako S, Adjei G, et al Evaluation of the diagnostic accuracy of CareStart G6PD deficiency Rapid Diagnostic Test (RDT) in a malaria endemic area in Ghana, Africa. PloS one. 2015; 10(4): e0125796 10.1371/journal.pone.0125796 25885097 PMC4401677 · doi:10.1371/journal.pone.0125796
  36. Baird JK, Dewi M, Subekti D, Elyazar I, Satyagraha AW. Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells. Transl Res. 2015; 165(6): 677– 88. 10.1016/j.trsl.2014.09.009 25312015 PMC4451869 · DOI · Paper page
  37. Alam MS, Kibria MG, Jahan N, Thriemer K, Hossain MS, Douglas NM, et al Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity. PloS one. 2018; 13(11): e0206331 10.1371/journal.pone.0206331 30388146 PMC6214512 · DOI · Paper page
  38. Ebstie YA, Abay SM, Tadesse WT, Ejigu DA. Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date. Drug Des Devel Ther. 2016; 10: 2387– 99. 10.2147/DDDT.S61443 27528800 PMC4970641 · DOI
  39. Devine A, Parmiter M, Chu CS, Bancone G, Nosten F, Price RN, et al Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis. PLoS neglected tropical diseases. 2017; 11(5): e0005602 10.1371/journal.pntd.0005602 28542194 PMC5460895 · DOI
  40. Robinson KM, Yang W, Haidar CE, Hankins JS, Jay DW, Kornegay N, et al Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies. Pharmacogenomics J. 2019; 19(3): 305– 14. 10.1038/s41397-018-0043-3 30206300 PMC6414283 · doi:10.1038/s41397-018-0043-3
  41. Shah SS, Macharia A, Makale J, Uyoga S, Kivinen K, Craik R, et al Genetic determinants of glucose-6-phosphate dehydrogenase activity in Kenya. BMC Med Genet. 2014; 15: 93 10.1186/s12881-014-0093-6 25201310 PMC4236593 · DOI · Paper page
  42. Johnson MK, Clark TD, Njama-Meya D, Rosenthal PJ, Parikh S. Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility. PloS one. 2009; 4(9): e7246 10.1371/journal.pone.0007246 19789650 PMC2748715 · DOI
  43. Alam MS, Kibria MG, Jahan N, Price RN, Ley B. Spectrophotometry assays to determine G6PD activity from Trinity Biotech and Pointe Scientific G6PD show good correlation. BMC Res Notes. 2018; 11(1): 855 10.1186/s13104-018-3964-7 30514365 PMC6278131 · DOI

Cited by

Metadata

Authors
Ley, B., Winasti Satyagraha, A., Rahmat, H., von Fricken, M. E., Douglas, N. M., Pfeffer, D. A., Espino, F., von Seidlein, L., Henriques, G., Oo, N. N., Menard, D., Parikh, S., Bancone, G., Karahalios, A., & Price, R. N.
Venue
PLOS Medicine
Published
2019-12-13
Volume
16
Issue
12
Pages
e1002992
ISSN
1549-1676
Cited by
48
References
1
Language
en
Funders
  • Menzies School of Health Research (Fellowship)
  • Department of Foreign Affairs and Trade, Australian Government (74431)
  • Bill and Melinda Gates Foundation (OPP1054404, OPP1164105)
  • Wellcome Trust (Senior Fellowship in Clinical Science, 200909)
  • Australian Centre for Research Excellence on Malaria Elimination (APP 1134989)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.